Result Summary for NUC105698
| Protocol ID: | NUC105698 |
| Clinical Study ID: | NUC105698 |
| Official Title: | A post-marketing surveillance to monitor the safety of Zeffix(Lamivudine) administered in Korean chronic hepatitis B virus infection subjects according to the prescribing information |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | lamivudine |
| Trade/Product Name: | HEPITEC,HEPTOVIR,ZEFIX,Zeffix,HEPTODIN,Epivir,EPIVIR-HBV |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
